Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Perspective Therapeutics, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 10 months agoperspectivetherapeutics.com
Perspective Therapeutics, Inc., commonly known as Perspective Therapeutics, is a pioneering US-based biopharmaceutical company. Headquartered in Corvallis, Oregon, this innovative firm operates within the pharmaceutical preparation manufacturing industry, focusing on cutting-edge oncology solutions.
The company specialises in developing next-generation radiopharmaceuticals for cancer treatment, particularly through Targeted Alpha Particle (TAP) therapy. Utilising proprietary technology, Perspective Therapeutics aims to deliver highly precise alpha-emitting radiopharmaceuticals, such as those derived from lead-212 (212Pb), directly to cancerous cells.
They are actively advancing a robust pipeline of therapeutic and diagnostic agents through clinical development. This unique approach to targeted radiation delivery positions Perspective Therapeutics at the forefront of precision oncology, offering significant potential for patients with difficult-to-treat cancers.
23
DitchCarbon score
-19 vs industry average
Perspective Therapeutics, Inc.’s score of 23 is lower than 36% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Perspective Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Perspective Therapeutics, Inc. yet.
Perspective Therapeutics, Inc.'s reported carbon emissions
Perspective Therapeutics, Inc., a US-headquartered company in the Pharmaceutical Preparation Manufacturing industry, has not publicly disclosed its carbon emissions data. The company has not announced any specific climate commitments or reduction targets.
Assessing Perspective Therapeutics, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Perspective Therapeutics, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Perspective Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Perspective Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Perspective Therapeutics, Inc.10 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more